论文信息 - LBA2 Impact of RNA expression signatures and tumour infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial - 字舞流文

LBA2 Impact of RNA expression signatures and tumour infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial

F. Feuerhake | O. Gluz | S. Kuemmel | H. Kreipe | E. Grischke | R. Kates | U. Nitz | R. Wuerstlein | M. Christgen | C. Eulenburg | J. Potenberg | M. Graeser | N. Harbeck | D. Augustin | C. Kolberg-Liedtke | M. Braun | J. Palatty | D. Ulbrich-Gebauer | C. Biehl